Case report of CRIA syndrome: progression from initial response to anakinra to sustained control with tocilizumab.

Hernández Sánchez J, García Olivas DJ, Machín García S, Hernández Beriain JÁ

Open source

DOI
10.1016/j.reumae.2026.502170
Published
2026 Aug-Sep
Container
Reumatologia clinica
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.reumae.2026.502170,
  title = {Case report of CRIA syndrome: progression from initial response to anakinra to sustained control with tocilizumab.},
  author = {Hernández Sánchez J and García Olivas DJ and Machín García S and Hernández Beriain JÁ},
  year = {2026},
  journal = {Reumatologia clinica},
  doi = {10.1016/j.reumae.2026.502170},
  url = {https://doi.org/10.1016/j.reumae.2026.502170}
}

RIS

TY  - JOUR
TI  - Case report of CRIA syndrome: progression from initial response to anakinra to sustained control with tocilizumab.
AU  - Hernández Sánchez J
AU  - García Olivas DJ
AU  - Machín García S
AU  - Hernández Beriain JÁ
PY  - 2026
JO  - Reumatologia clinica
DO  - 10.1016/j.reumae.2026.502170
UR  - https://doi.org/10.1016/j.reumae.2026.502170
ER  - 

APA

J, H. S., DJ, G. O., S, M. G., & JÁ, H. B. (2026). Case report of CRIA syndrome: progression from initial response to anakinra to sustained control with tocilizumab.. Reumatologia clinica. https://doi.org/10.1016/j.reumae.2026.502170

Source records